Application no. and date | 16756274.3 (espacenet) (Federated) (European Patent Register), 20160224 | Patent/reg. no. and date | DK/EP 3261721, 20220914 | Publication date | 20180103 | Priority no. and date | US 201562120771 P, 20150225, US 201562186221 P, 20150629 | EP pub. no. and date |
EP 3261721 20180103 | Effective date | | Applicant/owner | The Board of Regents of The University of Texas System, 201 West 7th Street
Austin, TX 78701, US, Prilenia Neurotherapeutics Ltd., 10 HaMenofim Street
Herzliya 4672561, IL | Applicant ref. no. | 15919 | Inventor | GEVA, Michal, Rozmarin 5 P.O.Box 7253
Even-Yehuda, IL, BEZPROZVANNY, Ilya,
Dallas, TX 75205, US, BASSAN, Merav,
Ramat Gan 5253179, IL, HAYDEN, Michael,
Herzliya 4672561, IL | Representative | COSMOVICI INTELLECTUAL PROPERTY, Rue de la Corraterie 5
1204 Geneva, CH | Opponent | | IPC Class | A61K 31/451 (2006.01) , A61P 25/28 (2006.01) , C07D 211/24 (2006.01) | Title | ANVENDELSE AF PRIDOPIDIN TIL FORBEDRING AF HUKOMMELSE | Int. application no. | US2016019357 | Int. publication no. | WO2016138130 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|